Blood-brain barrier transfer and cerebral uptake of antiepileptic drugs

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Blood-brain barrier transfer and cerebral uptake of antiepileptic drugs. / Paulson, O B; Györy, A; Hertz, M M.

I: Clinical Pharmacology and Therapeutics, Bind 32, Nr. 4, 10.1982, s. 466-77.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Paulson, OB, Györy, A & Hertz, MM 1982, 'Blood-brain barrier transfer and cerebral uptake of antiepileptic drugs', Clinical Pharmacology and Therapeutics, bind 32, nr. 4, s. 466-77. https://doi.org/10.1038/clpt.1982.190

APA

Paulson, O. B., Györy, A., & Hertz, M. M. (1982). Blood-brain barrier transfer and cerebral uptake of antiepileptic drugs. Clinical Pharmacology and Therapeutics, 32(4), 466-77. https://doi.org/10.1038/clpt.1982.190

Vancouver

Paulson OB, Györy A, Hertz MM. Blood-brain barrier transfer and cerebral uptake of antiepileptic drugs. Clinical Pharmacology and Therapeutics. 1982 okt.;32(4):466-77. https://doi.org/10.1038/clpt.1982.190

Author

Paulson, O B ; Györy, A ; Hertz, M M. / Blood-brain barrier transfer and cerebral uptake of antiepileptic drugs. I: Clinical Pharmacology and Therapeutics. 1982 ; Bind 32, Nr. 4. s. 466-77.

Bibtex

@article{47aac34317e14aedbccdc49c97f1de92,
title = "Blood-brain barrier transfer and cerebral uptake of antiepileptic drugs",
abstract = "The permeability across the blood-brain barrier of phenobarbital, phenytoin, clonazepam, and diazepam was determined in a total of 29 patients with the double-indicator dilution method. Cerebral blood flow was measured with the 133Xe intra-arterial injection method. The unidirectional extraction (E) of the four drugs was 0.07, 0.11, 0.42, and 0.42, respectively. Permeability surface area products (PS) calculated for the drugs depended on E as well as on the plasma protein binding of the drugs and the cerebral blood flow and was calculated as 0.1, 0.5, 0.5, and 2.6 ml gm-1 min-1, respectively. A mathematic model of cerebral uptake and concentration is presented. The brain concentration of each drug is then calculated for two different states, one with a sudden rise from zero to an arterial concentration, which remains constant, and the other with the arterial concentration, which is achieved after rapid intravenous injection. The cerebral uptake rate of clonazepam and diazepam was much more rapid than that of phenobarbital and phenytoin. After intravenous clonazepam or diazepam injection, half-maximal gray matter concentration is reached about 15 sec after the drug arrives at the brain.",
keywords = "Anticonvulsants/metabolism, Blood-Brain Barrier/drug effects, Brain/blood supply, Clonazepam/metabolism, Diazepam/metabolism, Humans, Models, Biological, Phenobarbital/metabolism, Phenytoin/metabolism, Time Factors",
author = "Paulson, {O B} and A Gy{\"o}ry and Hertz, {M M}",
year = "1982",
month = oct,
doi = "10.1038/clpt.1982.190",
language = "English",
volume = "32",
pages = "466--77",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "JohnWiley & Sons, Inc.",
number = "4",

}

RIS

TY - JOUR

T1 - Blood-brain barrier transfer and cerebral uptake of antiepileptic drugs

AU - Paulson, O B

AU - Györy, A

AU - Hertz, M M

PY - 1982/10

Y1 - 1982/10

N2 - The permeability across the blood-brain barrier of phenobarbital, phenytoin, clonazepam, and diazepam was determined in a total of 29 patients with the double-indicator dilution method. Cerebral blood flow was measured with the 133Xe intra-arterial injection method. The unidirectional extraction (E) of the four drugs was 0.07, 0.11, 0.42, and 0.42, respectively. Permeability surface area products (PS) calculated for the drugs depended on E as well as on the plasma protein binding of the drugs and the cerebral blood flow and was calculated as 0.1, 0.5, 0.5, and 2.6 ml gm-1 min-1, respectively. A mathematic model of cerebral uptake and concentration is presented. The brain concentration of each drug is then calculated for two different states, one with a sudden rise from zero to an arterial concentration, which remains constant, and the other with the arterial concentration, which is achieved after rapid intravenous injection. The cerebral uptake rate of clonazepam and diazepam was much more rapid than that of phenobarbital and phenytoin. After intravenous clonazepam or diazepam injection, half-maximal gray matter concentration is reached about 15 sec after the drug arrives at the brain.

AB - The permeability across the blood-brain barrier of phenobarbital, phenytoin, clonazepam, and diazepam was determined in a total of 29 patients with the double-indicator dilution method. Cerebral blood flow was measured with the 133Xe intra-arterial injection method. The unidirectional extraction (E) of the four drugs was 0.07, 0.11, 0.42, and 0.42, respectively. Permeability surface area products (PS) calculated for the drugs depended on E as well as on the plasma protein binding of the drugs and the cerebral blood flow and was calculated as 0.1, 0.5, 0.5, and 2.6 ml gm-1 min-1, respectively. A mathematic model of cerebral uptake and concentration is presented. The brain concentration of each drug is then calculated for two different states, one with a sudden rise from zero to an arterial concentration, which remains constant, and the other with the arterial concentration, which is achieved after rapid intravenous injection. The cerebral uptake rate of clonazepam and diazepam was much more rapid than that of phenobarbital and phenytoin. After intravenous clonazepam or diazepam injection, half-maximal gray matter concentration is reached about 15 sec after the drug arrives at the brain.

KW - Anticonvulsants/metabolism

KW - Blood-Brain Barrier/drug effects

KW - Brain/blood supply

KW - Clonazepam/metabolism

KW - Diazepam/metabolism

KW - Humans

KW - Models, Biological

KW - Phenobarbital/metabolism

KW - Phenytoin/metabolism

KW - Time Factors

U2 - 10.1038/clpt.1982.190

DO - 10.1038/clpt.1982.190

M3 - Journal article

C2 - 7116762

VL - 32

SP - 466

EP - 477

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 4

ER -

ID: 279620283